MTOR and breast cancer: Many other lncRNAs have also been reported to be capable of regulating PI3K/AKT/mTOR pathway, such as PTENP1 92, 93, MALAT1 94 and Xist 95, indicating the possible involvement of these lncRNAs in regulating resistance to the targeted therapies in BC (Figure 4A).